MIST — Milestone Pharmaceuticals Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1408443 ·
Last close
$0.41
Market Cap
$51.44M
52W High
$3.06
52W Low
$0.36
ADV30
1,692,724
Next earnings
2026-11-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 2,963,000 | 2,638,000 | -25,052,000 | -25,796,000 | 162,695,000 | 144,472,000 | 168,912,000 |
| Jun 2026 | 559,000 | 527,000 | -25,630,000 | -28,614,000 | 181,625,000 | 169,728,000 | 163,407,000 |
| Mar 2026 | 238,000 | 224,000 | -23,663,000 | -26,066,000 | 193,734,000 | 71,317,000 | 157,685,000 |
| Dec 2025 | 1,546,000 | — | -17,257,000 | -17,409,000 | 113,561,000 | 73,046,000 | 71,792,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-61,290,000
Investing CF
$-319,000
Financing CF
$188,838,000
CapEx
$-356,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.73
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-485,283,000
Inventory
$4,722,000
Receivables
$3,961,000
ST Investments
$881,000
EBIT TTM
$-73,199,000
Pretax Income TTM
$-84,011,000
Interest Exp TTM
$10,812,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,343,000
EBITDA
$-78,207,000
Free Cash Flow
$-41,687,376
Enterprise Value
$44,496,672
Total Cash
$170,608,992
Total Debt
$141,832,000
Shares Out
124,497,980
Trailing EPS
$-0.68
Book Value
$0.13
ROE
-35522.6%
ROA
-42.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,546,000 | -62,140,000 | -63,058,000 | 113,561,000 | 71,792,000 | 41,769,000 | -49,041,000 |
| Dec 2024 | 0 | -42,102,000 | -41,519,000 | 75,499,000 | 62,352,000 | 13,147,000 | -28,848,000 |
| Dec 2023 | 1,000,000 | -61,098,000 | -59,685,000 | 75,226,000 | 58,455,000 | 16,771,000 | -46,424,000 |
| Dec 2022 | 5,000,000 | -59,642,000 | -58,388,000 | 74,483,000 | 8,135,000 | 66,348,000 | -52,469,000 |
TTM Snapshot
Revenues TTM
$2,504,000
NetIncome TTM
$-84,011,000
OpCashFlow TTM
—
Assets (Latest)
$181,625,000
Forward EPS
$-0.75
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $0.50 · spot: $0.46 · call volume: 622 · put volume: 1
Expected Move to 2026-12-18:
±$0.12
(26.06%) —
implied range
$0.34 –
$0.58
· ATM straddle on $0.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HOWL | Werewolf Therapeutics, Inc. | $51.03M | $1.05 | — |
| AZR | Azora Therapeutics, Inc. (DE) | $52.36M | $3.66 | — |
| SPRO | Spero Therapeutics, Inc. | $52.51M | $0.90 | — |
| GANX | Gain Therapeutics, Inc. | $52.54M | $1.18 | — |
| IBIO | iBio, Inc. | $52.71M | $0.75 | — |
News headlines (Yahoo Finance, 1h cache)
Milestone Pharmaceuticals (MIST) Stock Sees Fair Value Cut As Cardamyst Launch Concerns Persist
2026-11-17 13:10 · Yahoo
Milestone Pharmaceuticals Inc. Q3 2026 Earnings Call Summary
2026-11-13 22:02 · Yahoo
Milestone Pharmaceuticals Q3 Earnings Call Highlights
2026-11-13 16:14 · Yahoo
Why Is Milestone Pharmaceuticals Stock Rising 6% Following Its Third-Quarter Results?
2026-11-13 13:33 · Yahoo
Milestone Pharmaceuticals Reports Third Quarter 2026 Financial Results and Announces Cost-Efficiency Measures Designed to Extend Cash Runway Through AFib-RVR Phase 3 Data
2026-11-13 12:08 · Yahoo
Milestone Pharmaceuticals (MIST) Reports Q3 Loss, Beats Revenue Estimates
2026-11-13 12:00 · Yahoo
Milestone Pharmaceuticals: Q3 Earnings Snapshot
2026-11-13 11:55 · Yahoo
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-11-04 01:45 · Yahoo
Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
2026-11-03 13:00 · Yahoo
New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation
2026-11-02 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.